Bookmark

Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

12 hrs ago | Seeking Alpha

Today's Market: Biotech Names Rallying Today

Our regular readers know that we have been using the idea of buying on the dips and searching for value while investing in this bull market the past few years.

Comment?

Related Topix: Biotech, Science / Technology, Medicine, Pfizer, Excaliard Pharmaceuticals, Healthcare Industry, Foldrx Pharmaceuticals

Tue Jul 22, 2014

Yahoo!

Mysterious white flags appear atop Brooklyn Bridge

Pfizer withdrew its sweetened bid for AstraZeneca on Monday, ending a takeover saga that began back in January.

Comment?

Related Topix: Entertainment, Drama, Television

Mon Jul 21, 2014

Forbes.com

One Put, One Call Option To Know About for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Financial Markets

Sun Jul 20, 2014

Customer Interaction Solutions

Global Hospital Infection Therapeutics Market: Industry Analysis,...

Albany, New York July 20, 2014 Hospital acquired infections are the infections acquired by the patients following the admission in hospitals within 48 hours.

Comment?

Related Topix: Albany, NY, E. Coli

Fri Jul 18, 2014

The Independent

US drugs giant finally seals A 32bn takeover of Shire

Note: We do not store your email address but your IP address will be logged to prevent abuse of this feature.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry

Wed Jul 16, 2014

Seeking Alpha

Why Pfizer Could Beat This Sector Peer

We pitch two companies from the pharmaceuticals sector, Pfizer and Novartis, against one another in the latest instalment of our Head-To-Head series.

Comment?

Related Topix: Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Novartis

BioSpace

Porter Novelli Appoints Senior Vice President Of Global Health & Wellness

Senior Vice President of Global Health and Wellness, leading key healthcare client engagements.

Comment?

Related Topix: Porter Novelli, Advertising, Public Relations, Marketing, Pfizer, Biotech, Medicine, Healthcare Industry, University of Arizona

Business Wire

Pfizer to Acquire InnoPharma, Inc.

Portfolio of 10 Approved Products and Pipeline of More Than 30 Products in Development; 19 Pending Approval with the United States Food and Drug Administration )--Pfizer Inc. and InnoPharma, Inc., a privately held pharmaceutical development company, today announced that they have entered into an agreement under which Pfizer will acquire InnoPharma.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Food and Drug Administration

BioSpace

Pfizer Inc. Hemophilia B Treatment Regimen Meets Endpoint In Phase 3 Trial

Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA Once-Weekly Prophylaxis For Hemophilia B - See more at: http://press.pfizer.com/press-release/pfizer-announces-positive-top-line-results-phase-3-study-nonacog-alfa-benefix-once-wee#sthash.YaBu8KgQ.dpuf Once-Weekly Prophylaxis Treatment with BeneFIXA Significantly Reduced ... (more)

Comment?

Related Topix: Hemophilia, Health, Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Healthcare Law, Law, Foldrx Pharmaceuticals

Seeking Alpha

Pfizer: Struggling Through A Tough Time

Top line had shrunk by 8% when the patent expired in Europe. The company had to launch a low-cost version, White Diamond, to stay afloat with the cut-throat competition.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, World News, China, Asia,

Applied Clinical Trials

immatics Receives ?22 Million Final Tranche of Series D Fundraising

Funds will be used to complete phase 3 study with IMA901 and to invest in the expansion of immatics ' Human Immunopeptidome Program to identify the most relevant targets for cancer immunotherapies immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company leading the development of advanced immunotherapies that are active against ... (more)

Comment?

Related Topix: Venture Capital, Emerging Technology, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals

Tue Jul 15, 2014

Pharmaceutical Processing

Bayer Names U.S. Head of Litigation

Bayer today announced the appointment of Malini Moorthy as Head of the Litigation Department in the United States, effective July 30. She succeeds Kaspar Stoffelmayr, whose three-year assignment ended and has rejoined Bartlit Beck Herman Palenchar & Scott LLP.

Comment?

Related Topix: Manufacturing, Bayer HealthCare, Chemicals, Pfizer, Biotech, Medicine, Healthcare Industry

Mon Jul 14, 2014

Forbes.com

One Put, One Call Option To Know About for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Financial Markets

The Washington Post

Kyocera, Applebee's, Pfizer, DuPont: Intellectual Property

Kyocera filed the lawsuit in Tokyo District Court July 10 after negotiations failed, the Kyoto-based company said in a statement.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, panels, Cholesterol, Health, Science / Technology

The Independent

Shire succumbs to A 31bn takeover offer from US rival AbbVie

The deal as it stands, A 24.44 in cash and 0.896 Abbvie shares, would give Shire's investors a 25% stake in the combined company Note: We do not store your email address but your IP address will be logged to prevent abuse of this feature.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry

Sun Jul 13, 2014

Bloomberg

U.K. to Tighten Rules for Foreign Bidders, Cable Says

The U.K. will tighten rules governing foreign takeovers of British companies to ensure bidders are held to commitments such as maintaining jobs, Business Secretary Vince Cable said.

Comment?

Related Topix: Conservatives (UK), Pfizer, Biotech, Medicine, Healthcare Industry

Tue Jul 08, 2014

Reuters

Pfizer wins dismissal of U.S. investor class action ahead of trial

The ruling by U.S. District Judge Laura Taylor Swain in New York came ahead of a Sept.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Bextra, Valdecoxib (generic), Celebrex, Celecoxib (generic), Health, Pain

Reuters

Pfizer wins dismissal of U.S. investor class action ahead of trial

Pfizer Inc won the dismissal Tuesday of a long-running shareholder class action accusing the company of misleading investors about the safety of its Celebrex and Bextra pain-relieving drugs.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Bextra, Valdecoxib (generic), Celebrex, Celecoxib (generic), Health, Pain

Reuters

Smoking cessation more effective with pills and patch: study

People trying to quit smoking may be more likely to succeed if they combine the patch with a pill, suggests a new study from South Africa.

Comment?

Related Topix: Smoking, Medicine, Health, Nicotine, NicoDerm, Nicotine (generic), Pfizer, Biotech, Healthcare Industry, World News, South Africa

Mon Jul 07, 2014

New York Post

Nonprofit heads for former Pfizer space

The Durst Organization, whose properties include One Bryant Park is scoring a rare 30-year condo commitment at 205 East 42nd Street.

Comment?

Related Topix: Manhattan, NY, New York, NY, Pfizer, Biotech, Medicine, Healthcare Industry, East 40s (New York, NY)

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••